Review on Inflammation Markers in Chronic Kidney Disease
Chronic kidney disease (CKD) is one of the major health problems of the modern age. It represents an important public health challenge with an ever-lasting rising prevalence, which reached almost 700 million by the year 2017. Therefore, it is very important to identify patients at risk for CKD devel...
Main Authors: | Tadej Petreski, Nejc Piko, Robert Ekart, Radovan Hojs, Sebastjan Bevc |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/2/182 |
Similar Items
-
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021-06-01) -
Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
by: Tadej Petreski, et al.
Published: (2020-01-01) -
Inflammatory Markers in Anorexia Nervosa: An Exploratory Study
by: Bethan Dalton, et al.
Published: (2018-10-01) -
Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy
by: Nina Vodošek Hojs, et al.
Published: (2020-09-01) -
Statin-Associated Necrotizing Myopathy Leading to Acute Kidney Injury: A Case Report
by: Tadej Petreski, et al.
Published: (2021-06-01)